Craft

Johnson & Johnson

Stock Price

$160.1

2024-10-29

Market Capitalization

$396.3 B

2024-08-26

Revenue

$94.2 B

FY, 2025

Johnson & Johnson Summary

Company Summary

Overview
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. It operates through three business segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes personal healthcare products used in baby care, oral care, beauty, women’s health, wound care, and other markets. The Pharmaceutical segment is focused on the therapeutic areas of immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism as well as pulmonary hypertension. The MedTech segment offers products used in the interventional solutions, orthopedics, surgery, and vision fields.
Type
Public
Status
Active
Founded
1886
HQ
New Brunswick, NJ, US | view all locations
Website
https://www.jnj.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Joaquin Duato

    Joaquin Duato, Chairman and Chief Executive Officer

  • Joseph J. Wolk

    Joseph J. Wolk, Executive Vice President, Chief Financial Officer

  • Peter Fasolo

    Peter Fasolo, Executive Vice President, Chief Human Resources Officer

  • Kathryn E. Wengel

    Kathryn E. Wengel, Executive Vice President, Chief Technical Operations & Risk Officer

Operating MetricsView all

Manufacturing Space, sq. ft.

14.9M

FY, 2022

Manufacturing Facilities (Europe)

27
8.0%

FY, 2022

Manufacturing Facilities (United States)

28
7.7%

FY, 2022

LocationsView all

42 locations detected

  • New Brunswick, NJ HQ

    United States

    1 Johnson And Johnson Plaza

  • Jacksonville, FL

    United States

    7500 Centurion Parkway, Suite 100

  • Buenos Aires, Cdad. Autónoma de Buenos Aires

    Argentina

    Mendoza 1259

  • Sydney, NSW

    Australia

    1-5 Khartoum Road

  • Vienna, Wien

    Austria

    Vorgartenstraße 206B

  • Minsk, Minsk Region

    Belarus

    Office 517, 5th Floor Myasnikova Street 70

and 36 others

Johnson & Johnson Financials

Summary Financials

Revenue (Q1, 2026)
$24.1B
Gross profit (Q1, 2026)
$16.0B
Net income (Q1, 2026)
$5.2B
Cash (Q1, 2026)
$21.7B
Enterprise value
$429.6B

Footer menu